SBIR/STTR Research Award

PhysioTelemeter for Autonomic Monitoring

Award identifier 0c8b95c07e041b83cf105fa9d1308e105a6f70d922da18c7bc4ca8b0bcb945d1Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$148,842

Program and phase

SBIR · Phase I

Award year

2005

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
INNERSEA TECHNOLOGY
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
PHS2005-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): A "PhysioTelemeter(tm)" system for physiological research and clinical monitoring of autonomic nervous system function in Spinal Cord Injury (SCI) and Diabetes is proposed. The system will allow non-invasive, unobtrusive, wireless monitoring of multiple physiological variables at multiple locations where long term use or freedom of movement is desirable. The Phase-1 system will consist of 3 battery powered PhysioTelemeters(tm), each transmitting on a unique radio frequency to a remote receiver and a computer for display and archive. Each telemeter will transmit data from 4 exemplary sensors (bioelectric, temperature, vibration and battery voltage) up to 10M in distance. The Phase-1 telemeters will be approximately the diameter and weight of a US quarter, but twice as thick, and will operate for over 8 hours from a lithium coin cell battery. This small size and light weight will allow measurements in active subjects with the PhysioTelemeters(tm) temporarily adhered to the skin over the regions of interest. Clinical collaborators for Phase-1 include a Physical Medicine and Rehabilitation clinician with expertise in SCI pathophysiology, and a physiologist with clinical expertise in dysautonomia in patients with diabetes. These collaborators will review and critique the technology at various stages to guide the technology, and will evaluate the system with limited human testing on healthy subjects in preparation for Phase-2, During Phase-2, clinical collaborators will utilize the Phase-1 prototype system extensively to determine the practical utility of the approach in their clinical practice and research. Two active measurements (skin perfusion and impedance) will be added. The system will be further optimized including use of custom integrated circuits to decrease size and power, increasing the range to 30M, adding 5 more frequency channels for a total of 8, developing an environmentally resistant package, and providing a rechargeable battery system.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.